APA (7th ed.) Citation

IH, S., JL, L., CE, G., HK, S., PD, S., & ED, D. (2023). Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs". The oncologist, 28(7), e588. https://doi.org/10.1093/oncolo/oyad130

Chicago Style (17th ed.) Citation

IH, Su, Lund JL, Gaber CE, Sanoff HK, Strassle PD, and Duchesneau ED. "Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs"." The Oncologist 28, no. 7 (2023): e588. https://doi.org/10.1093/oncolo/oyad130.

MLA (9th ed.) Citation

IH, Su, et al. "Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs"." The Oncologist, vol. 28, no. 7, 2023, p. e588, https://doi.org/10.1093/oncolo/oyad130.